These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36951885)

  • 1. HU for SCA in Africa: associated malaria benefit.
    Odame I
    Blood; 2023 Mar; 141(12):1370-1371. PubMed ID: 36951885
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
    Olupot-Olupot P; Tomlinson G; Williams TN; Tshilolo L; Santos B; Smart LR; McElhinney K; Howard TA; Aygun B; Stuber SE; Lane A; Latham TS; Ware RE
    Blood; 2023 Mar; 141(12):1402-1410. PubMed ID: 36375125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa.
    Tshilolo L; Tomlinson G; Williams TN; Santos B; Olupot-Olupot P; Lane A; Aygun B; Stuber SE; Latham TS; McGann PT; Ware RE;
    N Engl J Med; 2019 Jan; 380(2):121-131. PubMed ID: 30501550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.
    McGann PT; Williams TN; Olupot-Olupot P; Tomlinson GA; Lane A; Luís Reis da Fonseca J; Kitenge R; Mochamah G; Wabwire H; Stuber S; Howard TA; McElhinney K; Aygun B; Latham T; Santos B; Tshilolo L; Ware RE;
    Am J Hematol; 2018 Aug; 93(4):537-545. PubMed ID: 29318647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia.
    Opoka RO; Ndugwa CM; Latham TS; Lane A; Hume HA; Kasirye P; Hodges JS; Ware RE; John CC
    Blood; 2017 Dec; 130(24):2585-2593. PubMed ID: 29051184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
    Abdullahi SU; Wudil BJ; Bello-Manga H; Musa AB; Gambo S; Galadanci NA; Aminu H; Tijjani Gaya A; Sanusi S; Tabari MA; Galadanci A; Borodo A; Abba MS; Dambatta AH; Haliru L; Gambo A; Cassell H; Rodeghier M; Ghafuri DL; Covert Greene BV; Neville K; Kassim AA; Kirkham F; Trevathan E; Jordan LC; Aliyu MH; DeBaun MR
    Pediatr Hematol Oncol; 2021 Feb; 38(1):49-64. PubMed ID: 33236662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.
    McGann PT; Tshilolo L; Santos B; Tomlinson GA; Stuber S; Latham T; Aygun B; Obaro SK; Olupot-Olupot P; Williams TN; Odame I; Ware RE;
    Pediatr Blood Cancer; 2016 Jan; 63(1):98-104. PubMed ID: 26275071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
    Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
    Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of current and emerging strategies for reducing morbidity from malaria in sickle cell disease.
    Aneni EC; Hamer DH; Gill CJ
    Trop Med Int Health; 2013 Mar; 18(3):313-27. PubMed ID: 23320577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea.
    Santos B; Ginete C; Gonçalves E; Delgadinho M; Miranda A; Faustino P; Arez AP; Brito M
    Blood Cells Mol Dis; 2024 Mar; 105():102822. PubMed ID: 38215581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea lowers transcranial Doppler flow velocities in children with sickle cell anaemia in a Nigerian cohort.
    Lagunju I; Brown BJ; Sodeinde O
    Pediatr Blood Cancer; 2015 Sep; 62(9):1587-91. PubMed ID: 25847050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea Dose Escalation for Sickle Cell Anemia in Sub-Saharan Africa.
    John CC; Opoka RO; Latham TS; Hume HA; Nabaggala C; Kasirye P; Ndugwa CM; Lane A; Ware RE
    N Engl J Med; 2020 Jun; 382(26):2524-2533. PubMed ID: 32579813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia.
    Ballas SK; Connes P;
    Eur J Haematol; 2018 Dec; 101(6):798-803. PubMed ID: 30204261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous adjunctive treatment of malaria and its coevolved genetic disorder sickle cell anemia.
    Safeukui I; Ware RE; Mohandas N; Haldar K
    Blood Adv; 2023 Oct; 7(19):5970-5981. PubMed ID: 37093647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.
    Smart LR; Ambrose EE; Balyorugulu G; Songoro P; Shabani I; Komba P; Charles M; Howard TA; McElhinney KE; O'Hara SM; Odame J; Nakafeero M; Adams J; Stuber SE; Lane A; Latham TS; Makubi AN; Ware RE
    Acta Haematol; 2023; 146(2):95-105. PubMed ID: 35977532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.
    Darbari DS; Nouraie M; Taylor JG; Brugnara C; Castro O; Ballas SK
    Eur J Haematol; 2014 Apr; 92(4):341-5. PubMed ID: 24330217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea - An Essential Medicine for Sickle Cell Disease in Africa.
    Luzzatto L; Makani J
    N Engl J Med; 2019 Jan; 380(2):187-189. PubMed ID: 30625057
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyurea and stroke prevention in sickle cell anaemia: the challenge of application in sub-Saharan Africa.
    Diop S; de Montalembert M
    Lancet Haematol; 2023 Apr; 10(4):e237-e238. PubMed ID: 36870359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.